Outcomes from a new CV disease risk assessment tool show significant improvements in CV, kidney and metabolic health after bariatric surgery. The study also found a reduction in estimated 10 year risk of developing total CV disease and a reduction in the risk of developing heart failure one year after bariatric surgery.

In this short interview, Dr Danxia Yu (Vanderbilt University Medical Center, Nashville, US) discusses the outcomes from a study which applied a new CV disease risk assessment tool called PREVENT Equations to evaluate CV benefits of bariatric surgery. The study used electronic health records to form a cohort of patients free of CVD aged between 20 to 79 years old who underwent first time bariatric surgery between 1999 and 2022 at Vanderbilt University Medical Center.

Interview Questions:
1. What gaps in our understanding of bariatric surgery outcomes did you hope to address with this study?
2. What was the study design and patient population?
3. What were your key findings?
4. How might these findings influence the clinical decision-making process for patients considering bariatric surgery?
5. What future research questions emerged from this study that you'd like to explore?
6. Are there specific patient populations who might benefit from additional research on this topic?

Recorded remotely from Nashville, 2025.